Evaluating XPO1 Inhibitors in Multiple Myeloma and their Potential Role in Myelofibrosis - Episode 1

Coming Soon: Evaluating XPO1 Inhibitors in Multiple Myeloma and their Potential Role in Myelofibrosis

Expert hematologist-oncologists share insight on the evolving role of XPO1 inhibitor therapy in the management of multiple myeloma and myelofibrosis.